Biocon's conosldidated net profit surged 154.24% to Rs 344.50 crore in Q4 FY25, compared with Rs 135.50 crore in Q4 FY24.

While Dilip Buildcon Ltd. rose the most, REC Ltd. plummeted most among companies that announced their results for the quarter ...

Biocon reported a significant surge in Q4 net profit, up 153% to Rs 344 crore, with revenue growing 12% to Rs 4,454 crore.

Among many, companies like Ceigall India, Andhra Paper, DB Corp, and Muthoot Microfin also declard their Q4 results today.

The company said its Board approved a fundraise of up to Rs 4,500 crore and is also evaluating a potential merger of Biocon ...

Biotech firm Biocon on Thursday said its consolidated net profit surged over two-fold to Rs 344 crore in the fourth quarter ...

Quarterly Net Profit at Rs. 344.50 crore in March 2025 up 154.24% from Rs. 135.50 crore in March 2024. EBITDA stands at Rs. 1 ...

Indian biopharma firm Biocon's profit more than doubled in the fourth quarter, led by strong demand for its generics and biosimilar drugs in its key U.S. and European markets.

Biocon’s March quarter net profit jumped over 150% YoY to ₹344.5 crore, exceeding street expectations. Revenue, EBITDA and ...

Today, companies across sectors including Titan Company, L&T, Pidilite Industries, Asian Paints, Britannia Industries, Canara ...